Avoro Capital Advisors LLC Mersana Therapeutics, Inc. Transaction History

Avoro Capital Advisors LLC

  • $6.65 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$3.08 - $9.55 $3.62 Million - $11.2 Million
-1,175,000 Reduced 15.56%
6,375,000 $21 Million
Q2 2022

Aug 15, 2022
BUY
$2.84 - $5.0 $2.13 Million - $3.75 Million
750,000 Added 11.03%
7,550,000 $34.9 Million
Q3 2020

Nov 16, 2020
BUY
$16.2 - $25.7 $4.86 Million - $7.71 Million
300,000 Added 4.62%
6,800,000 $127 Million
Q2 2020

Aug 14, 2020
BUY
$5.24 - $23.4 $34.1 Million - $152 Million
6,500,000 New
6,500,000 $152 Million

Others Institutions Holding MRSN

# of Institutions
121
Shares Held
116M
Call Options Held
233K
Put Options Held
457K
View Full List

About Mersana Therapeutics, Inc.

MRSN Quotes by TradingView
  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $216M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track Avoro Capital Advisors LLC Portfolio

Follow Avoro Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avoro Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email